e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Surrogate markers of right ventricular adaptation better predict long-term survival in patients with PAH than traditional prognostic variables
F. Rischard, S. Knoper (Tucson, United States Of America)
Source:
Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Session:
Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Session type:
Thematic Poster Session
Number:
4093
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Rischard, S. Knoper (Tucson, United States Of America). Surrogate markers of right ventricular adaptation better predict long-term survival in patients with PAH than traditional prognostic variables. Eur Respir J 2013; 42: Suppl. 57, 4093
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry
Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019
Year: 2020
A dynamic prognostic model to predict survival and determine treatment goals in pulmonary arterial hypertension (PAH): the EFORT study
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019
Right ventricular function is a strong prognostic predictor of mortality in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Pressure-flow relationship during exercise predicts transplant-free survival in patients with pre-capillary pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights
Year: 2015
The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 589-596
Year: 2012
Validation of a prognostic score for pulmonary embolism short-term mortality
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis
Source: Eur Respir J, 51 (4) 1702427; 10.1183/13993003.02427-2017
Year: 2018
Relation between hemodynamics and right ventricular hypertrophy may affect survival and severity of the disease in patients with primary pulmonary hypertension (PPH)
Source: Eur Respir J 2002; 20: Suppl. 38, 26s
Year: 2002
Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes
Source: Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018
Year: 2019
Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes
Source: Eur Respir J, 53 (3) 1801894; 10.1183/13993003.01894-2018
Year: 2019
Clinical and haemodynamic predictors of abnormal pulmonary vascular response at exercise
Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights
Year: 2015
Baseline hemodynamic predictors of treatment response in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Biological markers predictors of pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 560s
Year: 2005
Right ventricular contractile reserve and pulmonary arterial compliance differentiate PAH patients with long-term survival and therapeutic success.
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Change of right heart size and function by long-term therapy with riociguat in patients with PAH and CTEPH
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
Hemodynamic predictors of survival in scleroderma related pulmonary hypertension: a single center study
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
Idiopathic pulmonary fibrosis: independent physiologic variables in the prediction of survival
Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis
Year: 2007
Risk stratification of pulmonary embolism: clinical evaluation, biomarkers or both?
Source: Eur Respir J 2015; 46: 1551-1553
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept